Litha Pharma is a division of Acino Healthcare Group and focuses on the following market areas.
Specialty Business Unit
General Practitioners and Specialists markets.
All products in this basket are classified from Schedule 3 above, consisting of 65% originator brands and 35% niche generics.
We focus in highly specialised areas with product ranges for Multiple Sclerosis, Iron Deficiency Anaemia, Dermatology, and Spasticity.
Other Key areas of focus are Urology, Cardiology, and Women’s Health.
Due to the specialised nature of the products in this portfolio it is essential there is a dual medical/commercial strategy to ensure these products ultimately find their way to the patient.
Hospital Business Unit
This business unit services corporate, independent and state hospitals with a range of life saving parenteral anti-infective agents, specifically in medical and surgical ICU’s, theatres and wards. The portfolio has both breadth and depth in the number of molecules we market to Hospitals with both oral and parenteral anti-infectives.
Our medical and commercial teams work synergistically with hospitals in South Africa driving anti-biotic stewardship and the responsible use of anti-infectives in the hospital setting both in the private sector and state.